Baker McKenzie has advised TTM Technologies, Inc. (“TTM”), a leading global manufacturer of technologically advanced electronic products and printed circuit board solutions, on two parallel acquisitions in Europe: the acquisition of Swiss Technology Group AG (“STG”), headquartered in Zurich, and the acquisition of ILFA Industrieelektronik und Leiterplattenfertigung aller Art GmbH (“ILFA”), headquartered in Hanover, Germany. Both transactions are subject to customary regulatory approvals and are expected to close in the third quarter of 2026.
With these acquisitions, TTM strengthens its presence in the European market and expands its technological capacities in strategically important application areas, especially in medical technology, aerospace, defense and other industrial markets. STG and ILFA complement TTM’s portfolio with specialized competencies in the development and manufacture of complex PCB solutions as well as miniaturized microcircuits. The Baker McKenzie team advised TTM comprehensively on the legal aspects of both transactions.
TTM Technologies, Inc. is a leading global manufacturer of technologically advanced electronic products, including mission systems, radio frequency components, microelectronic assemblies, and printed circuit boards and substrates. TTM stands for time-to-market and supports customers with time-critical design, engineering and manufacturing services to bring new products to market faster.
STG is a platform of GS Swiss and the Hofstetter Group. The company provides vertically integrated solutions for the most demanding medical applications and has particular expertise in highly miniaturized microcircuits as well as advanced coating and interconnect technologies.
ILFA is a German manufacturer of complex printed circuit board solutions. The owner-managed company employs around 190 people and has been developing high-tech solutions for 45 years, including for aerospace, defense, industry and medical technology.
The cross-border teams advising on the transactions were led by Corporate/M&A partners Dr. Matthias Courvoisier (Zurich), Daniel Dehghanian (Dusseldorf) and Tobias Knapp (New York) and included:
